Skip to main content
Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · IEX Real-Time Price · USD
21.61
+0.91 (4.40%)
May 31, 2024, 4:00 PM EDT - Market closed

Dianthus Therapeutics Revenue

Dianthus Therapeutics had revenue of $2.26M in the twelve months ending March 31, 2024, down -20.15% year-over-year. Revenue in the quarter ending March 31, 2024 was $874.00K with 83.61% year-over-year growth. In the year 2023, Dianthus Therapeutics had annual revenue of $2.83M, a decrease of -55.96%.

Revenue (ttm)
$2.26M
Revenue Growth
-20.15%
P/S Ratio
281.26
Revenue / Employee
$42,547
Employees
53
Market Cap
634.24M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.83M-3.59M-55.96%
Dec 31, 20226.42M--
Dec 31, 20210--
Dec 31, 20200--
Dec 31, 20190--
Dec 31, 20180--
Dec 31, 20170--
Dec 31, 20160--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Varex Imaging 855.80M
Definitive Healthcare 255.69M
Castle Biosciences 250.73M
Paragon 28 225.44M
Valneva SE 166.26M
Harrow Health 138.68M
Taysha Gene Therapies 14.16M
Arbutus Biopharma 12.99M
Revenue Rankings

DNTH News

More News